Literature DB >> 7390712

Effect of oral contraceptives on vitamin B6 nutriture of young women.

S C Vir, A H Love.   

Abstract

The effect of oral contraceptives (OC) on vitamin B6 status of young women was assessed by percentage stimulation of erythrocyte glutamic pyruvic transaminase (EGPT) activity. The subjects were studied under three groups--control (non OC users), cross-sectional study group (taking OC for over a period of 3 months) and follow up study group. No adverse effect of OC on mean basic EGPT, mean percentage stimulation level or in the incidence of deficiency was noted in cross-sectional study group as compared to controls. Similarly follow up of women before the initial of OC therapy and after a period of 3 months or 6 months usage also demonstrated no adverse effects on vitamin B6 nutriture. The vitamin B6 status showed no relationship with duration of OC use. Dietary vitamin B6 was below the recommended in majority of cases and showed no significant correlation with percentage stimulation of EGPT.

Entities:  

Keywords:  Age Factors; Biology; Comparative Studies; Contraception; Contraceptive Methods; Demographic Factors; Enzymes And Enzyme Inhibitors; Enzymes--analysis; Family Planning; Health; Hematological Effects; Hemic System; Nutrition; Oral Contraceptives; Physiology; Population; Population Characteristics; Research Methodology; Studies; Vitamin B Complex; Vitamins

Mesh:

Substances:

Year:  1980        PMID: 7390712

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  2 in total

1.  Hyperoxaluria and recurrent stone formation apparently cured by short courses of pyridoxine.

Authors:  A R Harrison; G P Kasidas; G A Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-27

Review 2.  Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Authors:  Emily S Mohn; Hua J Kern; Edward Saltzman; Susan H Mitmesser; Diane L McKay
Journal:  Pharmaceutics       Date:  2018-03-20       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.